Friday 19 Apr, 2019 10:32 AM
Site map | Locate Us | Login
   RIL advances as Mitsui to acquire stake     Jet Airways (India) Ltd leads losers in 'A' group    KM Sugar Mills Ltd leads losers in 'B' group    Volumes soar at Star Cement Ltd counter    Emami Ltd eases for fifth straight session    HDFC Life Insurance Company Ltd rises for fifth straight session    TVS Motor Company extends gains     Maruti Suzuki India Ltd stays in demand     Hero MotoCorp Ltd gains for fifth session    Essar Shipping Ltd leads gainers in 'B' group    SpiceJet Ltd leads gainers in 'A' group    SpiceJet jumps on plans to induct more planes     Volumes jump at Jamna Auto Industries Ltd counter    Wipro gains after share buyback approval    Jindal Steel & Power Ltd Falls 1.59% 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Metropolis Healthcare sees modest debut
15-Apr-19   11:10 Hrs IST

Meanwhile, the S&P BSE Sensex was up 94.59 points, or 0.24% to 38,861.70

Shares of Metropolis Healthcare debuted at Rs 960 on BSE, a premium of 9.09% to the initial public offer (IPO) price of Rs 880. So far the stock hit a high of Rs 970 and low of Rs 934.80. On BSE, so far 2.70 lakh shares were traded on the counter.

The initial public offer (IPO) of Metropolis Healthcare received bids for 4.47 crore shares, as per the National Stock Exchange of India (NSE) data. The issue was subscribed 5.84 times. The issue opened for subscription on 3 April 2019 and closed on 5 April 2019. The price band for the issue was fixed at Rs 877 to Rs 880 per share.

The qualified institutional buyers (QIBs) category was subscribed 8.88 times. The non-institutional investors category was subscribed 3.03 times. The retail individual investors (RIIs) category was subscribed 2.21 times.

On a consolidated basis, Metropolis Healthcare reported net profit of Rs 85.66 crore and net sales of Rs 559.31 crore in nine-months ended December 2018.

Incorporated in 1980 by Dr. Sushil Shah, Metropolis Healthcare is one of the leading diagnostics companies in India. The company offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease. Metropolis also offers analytical and support services to clinical research organizations for their clinical research projects. The company has presence across 19 states in India, as of 31 December 2018, with leadership position in the West and South India.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.G Anand , anand@ssplwealth.com
Hit Count : 10924606
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016  |  MCX : INZ000081736
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 12815 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. Saravana Stocks Pvt. Ltd